CAR T cell lymphoma trial opens for Aussie patients - Haematology Republic
Aussie CR confirmed in this article if it hasn't been posted already:
"Three patients in US arm of the trial have recently had complete responses to the therapy that has extended beyond 120 days. Earlier this month Imugene announced that the first Australian patient enrolled in the trial also displayed a complete response to the azer-cel therapy at their 28-day scan".
www.bloodrepublic.com.au/car-t-cell-lymphoma-trial-opens-for-aussie-patients/164
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $338.0K | 30.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 3480808 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 10994115 | 28 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |